Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5695-5695
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
Ilaria Vicenti, Maurizio Zazzi, Francesco Saladini
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 4, pp. 325-337
Open Access | Times Cited: 112
Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
Nicola Borbone, Gennaro Piccialli, Giovanni N. Roviello, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 986-986
Open Access | Times Cited: 70
RdRp inhibitors and COVID-19: Is molnupiravir a good option?
Seyed Mohammad Reza Hashemian, Mohammad Hossein Pourhanifeh, Michael R. Hamblin, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112517-112517
Open Access | Times Cited: 70
Molecular architecture of the Chikungunya virus replication complex
Yaw Bia Tan, David Chmielewski, Michelle Cheok Yien Law, et al.
Science Advances (2022) Vol. 8, Iss. 48
Open Access | Times Cited: 56
Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase
Federico Munafò, Elisa Donati, Nicoletta Brindani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles
Amgad M. Rabie
Chemico-Biological Interactions (2021) Vol. 343, pp. 109480-109480
Open Access | Times Cited: 48
Nucleosides and emerging viruses: A new story
Vincent Roy, Luigi A. Agrofoglio
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1945-1953
Open Access | Times Cited: 32
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
Liu Cao, Yingjun Li, Sidi Yang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 661
Open Access | Times Cited: 32
Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi
Susanne H. Kirsch, F. P. Jake Haeckl, Rolf Müller
Natural Product Reports (2022) Vol. 39, Iss. 6, pp. 1226-1263
Closed Access | Times Cited: 29
Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidates
Musa A. Said, Sayed M. Riyadh, Nadia S. Al‐Kaff, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 9, pp. 104101-104101
Open Access | Times Cited: 29
Small Molecule Drugs Targeting Viral Polymerases
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 661-661
Open Access | Times Cited: 8
Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
Jiří Patočka, Kamil Kuča, Patrik Olekšák, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 217-217
Open Access | Times Cited: 38
Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
Zhonglei Wang, Liyan Yang, Xian‐En Zhao
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4684-4701
Open Access | Times Cited: 36
Molecular Docking and Molecular Dynamics Simulation of Fisetin, Galangin, Hesperetin, Hesperidin, Myricetin, and Naringenin against Polymerase of Dengue Virus
Jaka Fajar Fatriansyah, Raihan Kenji Rizqillah, Muhammad Yusup Yandi
Journal of Tropical Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 27
Gossypol Broadly Inhibits Coronaviruses by Targeting RNA‐Dependent RNA Polymerases
Wenjing Wang, Wenkang Li, Zhiyuan Wen, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 27
Progression of Antiviral Agents Targeting Viral Polymerases
Siqi Peng, Huizhen Wang, Zhengtao Wang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7370-7370
Open Access | Times Cited: 24
The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics
Jarvis Z. H. Goh, Lachlan De Hayr, Alexander A. Khromykh, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 865-865
Open Access | Times Cited: 6
The Rise of Bacterial G-Quadruplexes in Current Antimicrobial Discovery
Stefano Ciaco, Rossella Aronne, Martina Fiabane, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 24163-24180
Open Access | Times Cited: 5
SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System
Jung Sun Min, Sunoh Kwon, Young-Hee Jin
Biomedicines (2021) Vol. 9, Iss. 8, pp. 996-996
Open Access | Times Cited: 30
Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 546-546
Open Access | Times Cited: 29
Alcohol-free synthesis, biological assessment, in vivo toxicological evaluation, and in silico analysis of novel silane quaternary ammonium compounds differing in structure and chain length as promising disinfectants
Ghada Tagorti, Burçin Yalçın, Merve Güneş, et al.
Journal of Hazardous Materials (2024) Vol. 466, pp. 133470-133470
Open Access | Times Cited: 4
SARS‐CoV‐2 NSP12 utilizes various host splicing factors for replication and splicing regulation
Li Yang, Xiao‐Tao Zeng, Rong‐Hua Luo, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 4
Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain
Amgad M. Rabie
Journal of Molecular Structure (2021) Vol. 1246, pp. 131106-131106
Open Access | Times Cited: 27
Computational identification of drug-like marine natural products as potential RNA polymerase inhibitors against Nipah virus
Jameel M. Abduljalil, Abdo A. Elfiky, El-Sayed T.A. Sayed, et al.
Computational Biology and Chemistry (2023) Vol. 104, pp. 107850-107850
Closed Access | Times Cited: 10
Recent advances and strategies in diagnostic tools, therapeutic and prophylactic measures
Dushyant Kumar, Awanish Kumar
Elsevier eBooks (2025), pp. 335-369
Closed Access
Page 1 - Next Page

Scroll to top